Webcast – presentation of the Q3 report 2022
Oncopeptides published its report for the third quarter 2022 on November 9 at 08.00 (CET). On the same day at 14:00 (CET) investors, analysts, and media were invited to participate in a webcast and a following QnA session. The event was hosted by Chief Executive Officer Jakob Lindberg, together with Chief Commercial Officer Sofia Heigis and Chief Financial Officer Annika Muskantor. The presentations was held in English.
The webcast was recorded and can be seen via https://ir.financialhearings.com/oncopeptides-q3-2022